Pulse Biosciences Director Robert Duggan Executes $13 Million Equity Purchase
Robert W. Duggan, a director and 10 percent shareholder of Pulse Biosciences, Inc. (NASDAQ:PLSE), has significantly increased his stake in the company through a substantial share acquisition. On May 11, 2026, Mr. Duggan purchased 660,233 shares of common stock for a total consideration of $12,999,987. The transaction was executed at a price of $19.…